NYSE : BAX

Baxter International Inc.

$27.6 USD

-$0.5 (-1.78%)

Volume
1.42M
Average Volume
6.91M
Market Capitalization
$14.27B
P/E Ratio
-13.53
Dividend Yield
0.72%
Price Target
$24.00
Year High
$30.00
Year Low
$15.73
Day High
—
Day Low
—
Payout Ratio
-$0.18
Current Ratio
$1.95
Company Overview

NYSE

Andrew Hider

Medical - Instruments & Supplies

Healthcare

BAX

37500

US

USD

https://www.baxter.com

224 948 2000

071813109

0000010456

Liquidity Metrics

1.56

1.95

1.32

0.60

-0.18

Sales & Valuation

$11.24B

1.24

2.30

21.05

1.31

Profitability

-$1.75

-$957M

-9.27%

-4.21%

-16.60%

-5.37%

P/E Metrics

-13.53

0.17

0.17

Analyst Price Target & Rating

$24.00

$28.00

$19.00

Sell

2/5

36 Analysts

15.00%

Financial Health Scores

2.32

4/9

$3.4B

$19.79B

$13.61B

-$203M

Key Metrics (TTM)

$22.04B

1.92

29.39

1.95

-16.60%

-1.61%

-7.32%

4.67%

115 days

Company Executives
Name Title
Andrew Hider Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director
Charles Rusty Patel Senior Vice President & Chief Information Officer
David S. Rosenbloom Executive Vice President & General Counsel
James W. Borzi Executive Vice President & Chief Supply Chain Officer
Steven Wallace President of Advanced Surgery & Commercial Excellence
Anita A. Zielinski Senior Vice President, Interim Chief Financial Officer, Chief Accounting Officer & Controller
Maria Soriano Group President of Infusion Therapies & Platforms
Stacey Eisen SVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation
Cynthia Carlisle Executive Vice President & Chief Human Resources Officer
Kevin Moran Vice President & Head of Investor Relations
Poll Results

No votes yet today — be the first to share your view!

About Baxter International Inc. (NYSE:BAX) Stock

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devic ... es vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.

Baxter Announces Cash Tender Offers

2026-08-04 08:30:00

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”), such that the aggregate purchase price, not including accrued and unpaid interest, payable in respect of such Notes will not exceed $500 million. The terms and c.

Baxter International Inc (BAX) Shares Surge 7.4% -- What GF Score of 66 Tells Investors

2026-08-03 19:08:00

On August 03, 2026, Baxter International Inc (BAX) shares rose 7.4% today, bringing the current price to $28.10. The stock has shown significant price performan

Baxter International: The Gains Can Continue, But Should Slow

2026-08-03 03:06:52

Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. BAX's valuation has expanded from distressed levels, now trading at ~13x earnings and ~9.5x EV/EBITDA, yet remains attractive if growth continues. Management's focus on operational improvements, cost savings, and a conservative outlook suggests potential for further upside if EPS growth materializes.

Why Baxter International Stock Skyrocketed by 19% This Week

2026-07-31 20:03:19

It scored double beats on analyst estimates. It also lifted its guidance on both the top and bottom lines.

Baxter International Inc (BAX) Shares Surge 8.0% -- What GF Score of 64 Tells Investors

2026-07-30 19:29:00

On July 30, 2026, Baxter International Inc (BAX) shares rose 8.0%, closing at $26.75. This increase comes amidst a volatile 52-week range, with shares oscillati

BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract

2026-07-30 13:06:13

Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.

Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript

2026-07-30 12:23:49

Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript

Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress

2026-07-30 11:33:29

Baxter International Inc. (NYSE:BAX) stock is trading higher on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.

Frequently Asked Questions

What is the current Baxter International Inc. (BAX) stock price?

Baxter International Inc.(NYSE:BAX) stock price is $27.6 in the last trading session. During the trading session, BAX stock reached the peak price of $30 while $15.73 was the lowest point it dropped to. The percentage change in BAX stock occurred in the recent session was --1.78% while the dollar amount for the price change in BAX stock was -$0.5.

BAX's industry and sector of operation?

The NYSE listed BAX is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of BAX?

Andrew Hider | Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director
Charles Rusty Patel | Senior Vice President & Chief Information Officer
David S. Rosenbloom | Executive Vice President & General Counsel
James W. Borzi | Executive Vice President & Chief Supply Chain Officer
Steven Wallace | President of Advanced Surgery & Commercial Excellence

How many employees does BAX have?

Number of BAX employees currently stands at 37500. BAX operates from One Baxter Parkway, Deerfield, IL 60015, US.

Link for BAX official website?

Official Website of BAX is: https://www.baxter.com

How do I contact BAX?

BAX could be contacted at phone #224 948 2000 and can also be accessed through its website. BAX operates from One Baxter Parkway, Deerfield, IL 60015, US.

How many shares of BAX are traded daily?

The average number of BAX shares traded daily for last 3 months was 6.91M.

What is the market cap of BAX currently?

The market value of BAX currently stands at $14.27B with its latest stock price at $27.6